Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app.

AccuStem Sciences, Inc. (OTCQB: ACUT ), a clinical stage diagnostics company dedicated to improving outcomes for patients ...

A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has hit its primary endpoint, setting ...

Detailed price information for Pmv Pharmaceuticals Inc (PMVP-Q) from The Globe and Mail including charting and trades.

Almirall, S.A. (ALM) a global biopharmaceutical company dedicated to medical dermatology, is a major contributor to the 2025 ...

Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the appointment of Rob ...

Abstract Title: Phase 3, Randomized, Placebo Controlled Clinical Trial of CAN-2409+Prodrug in Combination with Standard of Care External Beam Radiation (EBRT) for Newly Diagnosed Localized Prostate ...

Healthmine, a leading member engagement and rewards platform for health plans, announced a strategic partnership with Exact Sciences, a global leader in cancer diagnostics, to improve colorectal ...

TransMedics' growth is set to remain robust over the next 12 months, supported by its heart and lung clinical trials. Click ...

Data reinforce that mast cells are important drivers of CSU regardless of the underlying endotype and are consistent with the novel mechanism of action of barzolvolimab. Barzolvolimab is a promising ...

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).